Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance.

MLA

Acquier, M., et al. “Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance.” Open Forum Infectious Diseases, vol. 10, no. 2, Feb. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1093/ofid/ofad018.

APA

Acquier, M., Taton, B., Alain, S., Garrigue, I., Mary, J., Pfirmann, P., Visentin, J., Hantz, S., Merville, P., Kaminski, H., & Couzi, L. (2023). Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance. Open Forum Infectious Diseases, 10(2), 1–10. https://doi.org/10.1093/ofid/ofad018

Chicago

Acquier, M, B Taton, S Alain, I Garrigue, J Mary, P Pfirmann, J Visentin, et al. 2023. “Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance.” Open Forum Infectious Diseases 10 (2): 1–10. doi:10.1093/ofid/ofad018.